HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revlon debt

This article was originally published in The Rose Sheet

Executive Summary

Beauty marketer completed the first phase of debt reduction in exchange offer that expired March 19 for senior notes due 2006 and 2008, Revlon announces. Approximately $630 mil. of aggregate principal amount of notes were tendered for Revlon Class A common stock, representing approximately $190 mil. of notes in addition to those previously committed by majority shareholder MacAndrews & Forbes and Fidelity Management. MacAndrews & Forbes will exchange existing loans of approximately $173 mil. at the close of the exchange offer, bringing total debt reduction to more than $800 mil. and exceeding earlier estimates of $780 mil. Shareholder will hold approximately 60% of Revlon's stock and 70% voting rights. Funds managed by Fidelity will hold approximately 21% of the company's common stock and 12% of voting power, while other shareholders will hold 19% of the common stock representing 11% of voting power. Revlon unveiled its plan to cut debt earlier this year (1"The Rose Sheet" Feb. 16, 2004, p. 8)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012008

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel